How many clinical trials are tracked of bosentan?

16 trials are tracked, 1 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Dermatology Urology Ophthalmology Emergency Medicine Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

bosentan

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of bosentan

16 trials tracked of bosentan: 10 in phase 3 or 4 and 1 with published results. The most-cited published study has 45 citations.

16Trials tracked

10Phase 3 & 4

0Recruiting

1With published results

Phase distribution

Phase 4 3 Phase 3 7 Phase 1 3 Other / NA 3

Phase 3 Bosentan in Children With Pulmonary Arterial Hypertension Extension Study Completed · 45 cited
Phase 4 Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH) Completed
Phase 4 Combination Therapy in Pulmonary Arterial Hypertension Completed
Phase 4 Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension Completed
Phase 3 Effects of Two Dosing Regimens of Bosentan in Children With Pulmonary Arterial Hypertension Completed
Phase 3 FUTURE 3 Study Extension Completed

Show 10 more trials

Phase 3 Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Participants Completed
Phase 3 Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Completed
Phase 3 Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443 Completed
Phase 3 BUILD 3: Bosentan Use in Interstitial Lung Disease Completed
Phase 1 Influence of Bosentan on the Pharmacokinetics of Nintedanib Completed
Phase 1 A Study in Healthy Men to Test Whether Bosentan Influences the Amount of BI 425809 in the Blood Completed
Phase 1 Study to Evaluate the Effect of Bosentan on the Pharmacokinetics of Lurbinectedin in Patients With Advanced Solid Tumors Completed
N/A Endothelin Blockade in Patients With Single Ventricle Physiology Completed
N/A Bosentan and Pulmonary Endothelial Function Completed
N/A Influence of OATP1B1 and CYP2C9 Genotypes on the Pharmacokinetics of Bosentan Before and During Clarithromycin Completed

Showing the 16 most-cited and recently-updated of 16 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.